FTC sues important pharmacy gain supervisors more than insulin selling prices The company brought action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of daily life-conserving insulin medications. Insurers will keep on vertically integrating to help keep more earnings https://augustdyuqq.gynoblog.com/30067311/healthcare-news-an-overview